ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Post-Acute COVID-19 Syndrome
Human Influenza
Respiratory Tract Infections

COVID-19 trials near San Antonio, TX, USA:

A Study of mRNA-1283.222 Injection Compared With mRNA-1273.222 Injection in Participants ≥12 Years of Age to Prevent COVID-19 (NextCOVE)

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting
COVID-19
Biological: mRNA-1273.222
Biological: mRNA-1283.222

Phase 3

Moderna
Moderna

San Antonio, Texas, United States and 217 other locations

This is an exploratory Phase I, randomized, observer-blind, active-controlled, dose-escalation trial to evaluate four dose levels (DLs) of BNT162b4 g...

Active, not recruiting
COVID-19
SARS-CoV-2 Infection
Biological: BNT162b4 30 µg
Biological: BNT162b4 15 µg

Phase 1

BioNTech
BioNTech

San Antonio, Texas, United States and 16 other locations

The purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a singl-...

Active, not recruiting
COVID-19
Influenza, Human
Other: Normal saline placebo
Biological: BNT162b2 (Omi XBB.1.5)

Phase 2

Pfizer
Pfizer

San Antonio, Texas, United States and 29 other locations

randomized, placebo controlled, multicenter Phase 1/2 study to evaluate the safety, tolerability and efficacy of RJX in patients with COVID-....

Active, not recruiting
COVID-19
Acute Respiratory Distress Syndrome
Drug: Placebo Comparator
Drug: Rejuveinix (RJX) Active Comparator

Phase 1, Phase 2

Reven Pharmaceuticals

New Braunfels, Texas, United States and 2 other locations

be tolerated for treatment of pregnant women with mild or moderate COVID-19 compared to non-pregnant women with mild or moderate CO-...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 1

Pfizer
Pfizer

San Antonio, Texas, United States and 32 other locations

This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19. PBI--...

Active, not recruiting
COVID-19
Drug: PBI-0451 (Pomotrelvir)
Drug: Placebo

Phase 2

Pardes Biosciences

San Antonio, Texas, United States and 53 other locations

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Parent study Main Cohort)
Biological: AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152

Phase 2, Phase 3

AstraZeneca
AstraZeneca

San Antonio, Texas, United States and 214 other locations

The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vacci-...

Active, not recruiting
COVID-19
Influenza
Biological: COVID-19 Vaccine
Biological: Influenza and COVID-19 Combination A

Phase 3

BioNTech
BioNTech

San Antonio, Texas, United States and 157 other locations

The purpose of the study is to evaluate whether bemnifosbuvir (BEM) is effective and safe in adults with COVID-19 who do not need t...

Active, not recruiting
COVID-19
SARS CoV 2 Infection
Drug: Bemnifosbuvir (BEM)
Drug: Placebo

Phase 3

Atea Pharmaceuticals
Atea Pharmaceuticals

San Antonio, Texas, United States and 263 other locations

This Phase 2/3 trial evaluates four treatment strategies for non-critically ill hospitalized participants (not requiring ICU admission and/or mechani...

Enrolling
Severe Acute Respiratory Syndrome Coronavirus 2
Severe Acute Respiratory Infection
Combination Product: NA-831and Dexamethasone
Drug: Drug: NA-831

Phase 2, Phase 3

NeuroActiva

Fort Sam Houston, Texas, United States and 30 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems